Reason: AMGN is the closest name in the basket to a fresh 52-week high at -1.33%, though RSI 70.3 flags it near-overbought inside a breakout regime; TMO holds a similar RSI in the low 60s despite being death-crossed; VRTX and MRNA sit in steadier golden-cross structures with unrated theses.

Tape Read

$AMGN is tightest to a fresh high in the group: price $415.21, RSI 70.3 (near-overbought), golden-cross, regime breakout, thesis unrated, 7D +1.04%, 30D +15.88%, just -1.33% off its 52-week high. $TMO: price $588.29, RSI 63.2, death-crossed despite a breakout regime, thesis intact, 7D -0.96%, 30D +9.9%, -8.47% off its high. $VRTX: price $505.75, RSI 56.5, golden-cross, regime uptrend, thesis unrated, 7D +1.95%, 30D +6.01%, -7.4% off its high. $MRNA: price $63.32, RSI 56.6, golden-cross, regime pullback, thesis unrated, 7D +7.01%, 30D -7.26%, still -26.03% off its high. Source: full-scan pre-computed summaries as of the 2026-08-14 close — biotech ($MRNA, $VRTX, $TMO) and biotech-scan ($AMGN, tracked outside the core biotech watchlist).

• $AMGN — WATCH: RSI 70.3 (near-overbought), golden-cross, regime breakout, -1.33% off its 52-week high — the group's tightest name to a fresh high, but the RSI level argues for caution rather than chasing.
• $TMO — WATCH: RSI 63.2, death-crossed despite a breakout regime, thesis intact — the cross and the regime disagree.
• $VRTX — WATCH: RSI 56.5, golden-cross, regime uptrend, thesis unrated.
• $MRNA — WATCH: RSI 56.6, golden-cross, regime pullback, thesis unrated, still -26.03% off its 52-week high despite a +7.01% week.

Lead pick: $AMGN is the closest name to a fresh high in the basket, but RSI 70.3 puts it near the overbought line inside an already-extended breakout regime — the setup argues for watching rather than adding. No name in this basket clears a clean PROMOTE bar this cycle.

Sources

• Tape data (price/RSI/SMA/returns): full-scan pre-computed summaries as of the 2026-08-14 close — biotech ($MRNA, $VRTX, $TMO) and biotech-scan ($AMGN, tracked outside the core biotech watchlist).